Who
Zurit Levine
SVP, Business Development
Company insider
Files Form 4 as: SVP, Business Development, Compugen.
In numbers
- Trades disclosed
- 74
- Buys
- 0
- Sells
- 9
- Bought
- $0
- Sold
- $167K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 26 Mar 2026
- Last trade
- 29 Jul 2026
- Last filed
- 30 Jul 2026
Companies traded
Activity over time
1 Mar – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 29 Jul 2026filed 30 Jul 2026 | CGEN CompugenBiotechnology | SEC FORM 4 Code A | —18,000 at $0.00 | filing |
| 29 Jul 2026filed 30 Jul 2026 | CGEN Compugenoption or derivative · Biotechnology | SEC FORM 4 Code A | —24,000 at $0.00 | filing |
| 29 Jul 2026filed 30 Jul 2026 | CGEN Compugenoption or derivative · Biotechnology | SEC FORM 4 Code A | —24,000 at $0.00 | filing |
| 29 Jul 2026filed 30 Jul 2026 | CGEN CompugenBiotechnology | SEC FORM 4 Code A | —18,000 at $0.00 | filing |
| 9 Jul 2026filed 13 Jul 2026 | CGEN CompugenBiotechnology | SEC FORM 4 Code M | $1,5551,875 at $0.8292 | filing |
| 9 Jul 2026filed 13 Jul 2026 | CGEN CompugenBiotechnology | SEC FORM 4 Sold | $4,6881,875 at $2.50 | filing |
| 9 Jul 2026filed 13 Jul 2026 | CGEN Compugenoption or derivative · Biotechnology | SEC FORM 4 Code M | —1,875 at $0.00 | filing |
| 9 Jul 2026filed 13 Jul 2026 | CGEN Compugenoption or derivative · Biotechnology | SEC FORM 4 Code M | —1,875 at $0.00 | filing |
| 9 Jul 2026filed 13 Jul 2026 | CGEN CompugenBiotechnology | SEC FORM 4 Code M | $1,5561,875 at $0.83 | filing |
| 9 Jul 2026filed 13 Jul 2026 | CGEN CompugenBiotechnology | SEC FORM 4 Sold | $4,6881,875 at $2.50 | filing |
| 24 Apr 2026filed 27 Apr 2026 | CGEN CompugenBiotechnology | SEC FORM 4 Code M | $2,3002,000 at $1.15 | filing |
| 24 Apr 2026filed 27 Apr 2026 | CGEN CompugenBiotechnology | SEC FORM 4 Sold | $6,4002,000 at $3.20 | filing |
| 24 Apr 2026filed 27 Apr 2026 | CGEN Compugenoption or derivative · Biotechnology | SEC FORM 4 Code M | —2,000 at $0.00 | filing |
| 24 Apr 2026filed 27 Apr 2026 | CGEN Compugenoption or derivative · Biotechnology | SEC FORM 4 Code M | —2,000 at $0.00 | filing |
| 24 Apr 2026filed 27 Apr 2026 | CGEN CompugenBiotechnology | SEC FORM 4 Code M | $2,3002,000 at $1.15 | filing |
| 24 Apr 2026filed 27 Apr 2026 | CGEN CompugenBiotechnology | SEC FORM 4 Sold | $6,4002,000 at $3.20 | filing |
| 14 Apr 2026filed 15 Apr 2026 | CGEN CompugenBiotechnology | SEC FORM 4 Code M | $2,3002,000 at $1.15 | filing |
| 14 Apr 2026filed 15 Apr 2026 | CGEN CompugenBiotechnology | SEC FORM 4 Sold | $5,6002,000 at $2.80 | filing |
| 14 Apr 2026filed 15 Apr 2026 | CGEN Compugenoption or derivative · Biotechnology | SEC FORM 4 Code M | —2,000 at $0.00 | filing |
| 14 Apr 2026filed 15 Apr 2026 | CGEN Compugenoption or derivative · Biotechnology | SEC FORM 4 Code M | —2,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.